TABLE 4

Haplotype frequencies according to the prospective risk of hyperglycemia

HaplotypeHyper-glycemicNormo-glycemic
−11391G-11377C0.6460.646χ2 = 6.60, df = 3, 0.05 < P < 0.10
−11391G-11377G0.2310.261
−11391A-11377C0.1130.091
−11391A-11377G0.0090.001
−11391G-45T0.7510.800χ2 = 7.12, df = 3, 0.05 < P < 0.10
−11391G-45G0.1270.108
−11391A-45T0.0870.071
−11391A-45G0.0350.022
−11391G-276G0.6890.707χ2 = 4.94, df = 3, 0.10 < P < 0.25
−11391G-276T0.1870.200
−11391A-276G0.0420.028
−11391A-276T0.0810.064
−11377C-276G0.4990.491χ2 = 3.28, 3 df = 3, 0.25 < P < 0.50
−11377C-276T0.2610.246
−11377G-276G0.2350.244
−11377G-276T0.0050.019
−11377C-45T0.6140.624χ2 = 4.78, 3 df = 3, 0.10 < P < 0.25
−11377C-45G0.1480.114
−11377G-45T0.2240.247
−11377G-45G0.0140.016
45T-276G0.5810.608χ2 = 7.38, df = 3, 0.05 < P < 0.10
45T-276T0.2560.262
45G-276G0.1500.127
45G-276T0.0130.003